Novel Soluable Gamma-Secretase Modulators
Researchers:
Funding year(s):
2010
Funding to date:
$250,000
Building on in vitro characterization of a novel series of soluable gamma-secretase modulators (SGSMs) funded by Cure Alzheimer’s Fund, the current project is a thorough pharmacological or in vivo examination of these molecules to identify the best or “lead” drug candidate.
